ARCH Medical Solutions ’s Post

🎗 Nominations are closing soon for the MTAA MedTech Industry Awards. Nominate via the Awards Force platform: https://lnkd.in/gFAsYcSM   The Awards are highly regarded within the industry and a key event on the MedTech calendar. Five nomination categories are available to recognise individuals and companies who have significantly contributed to the industry. ➡ Kerrin Rennie The Kerrin Rennie Award for Excellence in Medical Technology - Improving Quality of Life was established to recognise and profile the innovative and extraordinary contribution of medical technology in improving the health outcomes of Australian patients. ➡ Outstanding Achievement This award recognises an individual who has contributed in an exceptional way to the medical technology industry in Australia. This may be evident through their contribution to industry development, improvement in patient outcomes or excellence in leadership or innovation. ➡ Women in MedTech (Individual and Company) The Women in MedTech Awards are presented to both individuals and companies that have been leaders in advancing or achieving significant gains in gender equity. ➡ Women in MedTech Emerging Women in Leadership The Women in MedTech Award for Emerging Women in Leadership celebrates an inspiring, emerging female leader in the medical technology industry. This is exclusively for MTAA members. Nominations close on Friday, 6 September 2024. Nominees and winners announced on Wednesday, 23 October 2024. Nominate via the Awards Force platform: https://lnkd.in/gFAsYcSM #MedTech #Awards

𝐋𝐢𝐟𝐭 𝐔𝐩: 𝐒𝐡𝐚𝐩𝐢𝐧𝐠 𝐭𝐡𝐞 𝐅𝐮𝐭𝐮𝐫𝐞 - 𝐀𝐝𝐯𝐚𝐧𝐜𝐢𝐧𝐠 𝐈𝐧𝐜𝐥𝐮𝐬𝐢𝐯𝐢𝐭𝐲 𝐢𝐧 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐓𝐫𝐢𝐚𝐥𝐬 Are clinical trials paving the way for tomorrow's health and helping build a more inclusive healthcare system for all? Join us on a Lift Up: Women in Life Sciences Live Broadcast where we look to delve into this topics with three industry experts and be a part of our fascinating interactive panel hosted by Louise Williams (nee Wraight), on Thursday 14th November. Clinical trials are the cornerstone of making treatments and medicines a reality, making them accessible to us. But that accessibility is compromised if clinical trials aren’t inclusive, causing certain groups to miss out on potentially life saving treatment. To investigate this topic, we feel privileged to welcome our panel of industry experts including Karen Correa, PhD (Vice Chairman of the Board at CAMcare Health Corporation), Mg Wong (Vice President, RA/QA Advisor, Med Tech Start-ups | Silicon Valley VC/Angel Network ), and Ann E. Taylor, M.D. (Multi Board Member | Consultant | Clinician). 𝐎𝐮𝐫 𝐝𝐢𝐬𝐜𝐮𝐬𝐬𝐢𝐨𝐧 𝐜𝐨𝐯𝐞𝐫𝐬: 👉What’s the reality of now and the magnitude of awareness 👉How big is the challenge of inclusivity in trials 👉How can leadership in organisations be the solution for tomorrow 👉Looking Ahead for future inclusivity and diversity Don't miss this opportunity to hear from trailblazing women from academia to C-Suite, discussing this conversation on a live Q&A segment during the LinkedIn broadcast, giving you the chance to engage directly with our industry leaders. So come join us! https://lnkd.in/eSJx48we

ICYMI... We are back with a live event you really don't want to miss! In this live broadcast we will be joined by Deborah Kilpatrick, Executive Chair of the Board at Evidation Health. Having held a variety of executive leadership and board director positions, with broad experience in development and commercialization of health care technologies, Deborah has some unrivalled insights into the industry and is well informed to give predictions for the future of healthcare. As well as Deborah’s incredibly impressive career, she is Co-Founder of the first conference for women business leaders, investors, clinicians, and commercialization experts building the MedTech sector's future, now held annually in Silicon Valley. Deborah will give us a unique perspective into the nuances of executive leadership and board seats, the state of play in the MedTech industry and of course, the future for Women in MedTech. This is Real Talk. With Real Execs. No marketing. No scripts. Just unfiltered conversations with respected executives across the ecosystem. We will aim to cut through the noise and give a real representation of the market and as ever, try to add value to current and future leaders in MedTech. There will of course be opportunity for questions to be fired into our guests throughout each event. Don't miss out on this opportunity to gain unparalleled insights and connect with thought leaders and professionals transforming healthcare. Register now to secure your spot. #medtech #insidemedtech #executiveleadership #womeninmedtech

Looking forward to the discussion with these panelists February 19 at AUTM in San Diego about the economic impact of women's health research now and the potential that more investment can make. Women's Health Access Matters #3not30

Excited to attend #ViVE2024 in Los Angeles, representing Bliss Bio Health with Gloria Vanderham for a 4-day exploration of the healthcare industry’s future! Looking forward to exploring critical topics around digital health, artificial intelligence, cybersecurity, care delivery, governance, data science, and health policy. 🤝 #HealthcareInnovation #DigitalHealth #AI #Cybersecurity #HealthPolicy

One of the best things about my work is learning from experts. Recently I spoke with Jean Balgrosky, PhD, MPH, RHIA on her impressive career journey. A trailblazer, Jean saw the opportunity early on to harness rich healthcare data for more proactive care. #MDRevolution #RemoteCareManagement #ChronicCareManagment #RemotePatientMonitoring

Advancing the importance of Health Equity + Pharmacoequity with a #equitable clinical trials outcome... together.

"Collaboration" was a key theme during day 4 of the 2024 Women of Color in Pharma (WOCIP) Cluster Meetings. #Collaboration with the right people, such as community healthcare providers and patient advocacy groups, is crucial. By understanding the specific challenges faced by marginalized communities, companies can more purposely select and leverage technology effectively to design solutions that truly address health equity concerns. To bridge the gap between pharmaceutical companies' resource allocation and the growing need for health equity initiatives, companies can use #technology as a tool to address these disparities and need to adopt a "purposeful #vision" approach. This means clearly defining the target audience, desired impact, and timelines before starting any project. Quotes from LaToya Coffey, PhD, Charlotte Jones-Burton, MD, MS, and Rizwana Seeham Key Takeaways from Clarkston's Brandon Miller, Erica Parks Murray, and LaToya Lee Jones Learn more about the importance of #equitable clinical trials here: https://lnkd.in/eHi-YwET

Ensuring diversity in clinical trials is not only an equity issue but critical for generating accurate, reliable research results. Recently, CTTI’s Sabrena Mervin-Blake, Senior Project Manager and Lead for Diversity, Equity, and Inclusion, sat down with Xtalks to discuss key strategies for promoting inclusivity in clinical trials.  In the interview, Sabrena dives deep into the actionable steps organizations can take – from fostering partnerships with patient groups to holding leadership accountable for diversity efforts. Learn how CTTI is leading the charge to make clinical research more representative and equitable for all, and explore how your organization can be part of the change! https://bit.ly/3B7poz5